Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Aging-related hormone changes affect voice quality, especially during puberty, menstruation, pregnancy, and menopause.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Low iron levels are linked to hair loss in women.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Moxibustion may help improve ovarian function by changing androgen levels.

Using 448-kHz Capacitive-Resistive Electrothermal Therapy can help increase hair density and prevent hair loss in women.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hormonal therapies, especially antiandrogens, can help manage Hidradenitis Suppurativa.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.